| 91 | DBT-BIRAC supported indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III clinical trials | 03/01/2021 | Details |
| 92 | Indian SARS-CoV-2 Genomic Consortia (INSACOG) launched,coordinated by Department of Biotechnology (DBT) along with MoH&FW, ICMR, and CSIR | 30/12/2020 | Details |
| 93 | Indigenous mRNA vaccine candidate supported by DBT gets Drug Controller nod to initiate Human clinical trials | 11/12/2020 | Details |
| 94 | Government Launches Mission COVID Suraksha to accelerate Indian COVID-19 Vaccine Development | 29/11/2020 | Details |
| 95 | Dr. Harsh Vardhan inaugurates the “DBT-BIRAC Clean Tech Demo Park” at Barapullah drain site | 08/10/2020 | Details |
| 96 | DBT-THSTI recognized as a Global Bioassay Laboratory to assess COVID 19 Vaccine by CEPI | 05/10/2020 | Details |
| 97 | DBT – ICAR Transfer of Technology of novel Brucella vaccine viz. Brucella abortusS19 delta per vaccine | 25/09/2020 | Details |
| 98 | “Biotechnology sector is recognized as the key driver for contributing to India's $ 5 Trillion economy target by 2024” -- Dr Harsh Vardhan | 24/09/2020 | Details |
| 99 | Department of Biotechnology launches Programme for “Strengthening Clinical Trial Research Capacity in Neighbouring Countries” | 23/09/2020 | Details |
| 100 | Nearly 30 Covid vaccine candidates are under various stages of development, by both industry and academia | 18/09/2020 | Details |
